Location History:
- Derwood, MD (US) (2008)
- Denwood, MD (US) (2011 - 2015)
Company Filing History:
7 out of 130 
1 out of 832,761 Years Active: 2008-2015
Title: Maria Concetta Veri: Innovator in Antibody Therapeutics
Introduction
Maria Concetta Veri is a prominent inventor based in Denwood, MD (US), known for her significant contributions to the field of antibody therapeutics. With a total of 8 patents to her name, she has made remarkable strides in developing innovative solutions for cancer treatment and immune regulation.
Latest Patents
Her latest patents focus on FcγRIIB specific antibodies and their methods of use. These inventions relate to antibodies or fragments that specifically bind to the extracellular domain of FcγRIIB, particularly human FcγRIIB. The patents describe methods for treating cancer and regulating immune complex-mediated cell activation by administering these antibodies to enhance immune responses. Additionally, her inventions encompass the use of anti-FcγRIIB antibodies as single-agent therapies for various cancers, autoimmune disorders, and allergic conditions. The patents also detail pharmaceutical compositions that include these antibodies, aimed at improving therapeutic efficacy and vaccine effectiveness.
Career Highlights
Throughout her career, Maria has worked with notable companies, including Macrogenics, Inc. Her work has significantly impacted the development of antibody-based therapies, showcasing her expertise and dedication to advancing medical science.
Collaborations
Maria has collaborated with esteemed colleagues such as Scott Koenig and Nadine Tuaillon, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Maria Concetta Veri stands out as a leading inventor in the field of antibody therapeutics, with her innovative patents paving the way for new treatment options in oncology and immunology. Her work continues to inspire advancements in medical research and therapeutic development.